title: Phase I/II trial of high-dose cytosine arabinoside and mitoxantrone in adult refractory acute myeloid leukemia.
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
authors.forename: H
authors.initials: H
authors.lastname: Kreutzmann
authors.forename: K
authors.initials: K
authors.lastname: Straif
authors.forename: W D
authors.initials: WD
authors.lastname: Ludwig
authors.forename: H J
authors.initials: HJ
authors.lastname: Fuhr
authors.forename: R
authors.initials: R
authors.lastname: Donhuijsen-Ant
authors.forename: E
authors.initials: E
authors.lastname: Lengfelder
authors.forename: T
authors.initials: T
authors.lastname: Büchner
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005860:Germany, West; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008942:Mitoxantrone / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D008942:Mitoxantrone